なぜgenOwayなのか？

予測不可能な前臨床モデルは、臨床試験の失敗の一因となる

‍

Over 95% of drug candidates fail during clinical trials. One of the key reasons: preclinical models often fail to predict how drugs will behave in humans.  Even if two models look similar or have the same humanized gene, their ability to predict human outcomes can be radically different. This is why choosing the right preclinical model is critical to generating reliable data.

At genOway, we focus on delivering ultimate predictability by developing models that better reflect human biology and help to generate more translatable preclinical data We have developed a portfolio of physiologically relevant mouse models, validated in collaboration with biopharma   partners, to evaluate immunotherapies in oncology, inflammation, and autoimmune diseases before they advance to clinical trials.

genOwayが前臨床および臨床試験の結果に及ぼす実証済みの効果

genOwayのモデルは、ますます多くのIND申請に対応しています。  

‍

これらはオプディボ®などの治療法の評価に貢献しており、大手バイオ医薬品企業によって、革新的な免疫療法を臨床段階へと進めるために活用されています。